A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

NCT03915964 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2663

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Baricitinib
DRUG: TNF Inhibitor

Sponsor

Eli Lilly and Company

Collaborators

[object Object]